Absent T Lymphocytes

Search Trials
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy – ACE Inhibitor Therapy Trial
Status:
Completed
Last Changed:
May 4, 2015
First Changed:
May 4, 2015
Disease(s):
Myocardial Fibrosis
Intervention(s):
Enalapril
The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
Status:
Terminated
Last Changed:
Jan 14, 2020
First Changed:
Jan 12, 2016
Disease(s):
Muscular Dystrophy
Intervention(s):
Tadalafil 20 MGbeetroot juice extract
Mother-caregivers of Children With Duchenne Muscular Dystrophy
Status:
Completed
Last Changed:
Feb 3, 2016
First Changed:
Aug 13, 2013
Disease(s):
Other Diseases or Conditions
Intervention(s):
sleep parametersHormonal profileInflammatory profileCardiovascular profileMetabolic profile
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Status:
Recruiting
Last Changed:
Mar 25, 2022
First Changed:
Mar 25, 2022
Disease(s):
Sarcoma, Synovial
Intervention(s):
CYCLOPHOSPHAMIDE and FLUDARABINCyclophosphamideHBI 0201-ESO TCRTAldesleukin
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Status:
Recruiting
Last Changed:
Feb 9, 2022
First Changed:
Feb 8, 2022
Disease(s):
Solid Tumor, Adult
Intervention(s):
Tumor Biopsy
A Study to Investigate LYL797 in Adults With Solid Tumors
Status:
Recruiting
Last Changed:
Mar 31, 2022
First Changed:
Mar 10, 2022
Disease(s):
Triple Negative Breast Cancer
Intervention(s):
LYL797
A Study of NX-1607 in Adults With Advanced Malignancies
Status:
Recruiting
Last Changed:
May 23, 2022
First Changed:
Nov 4, 2021
Disease(s):
Ovarian Cancer, Epithelial
Intervention(s):
NX-1607
Long-term Follow-up of Subjects Treated With CARv3-TEAM-E T Cells
Status:
Not yet recruiting
Last Changed:
Aug 27, 2021
First Changed:
Aug 27, 2021
Disease(s):
Glioblastoma Recurrent, EGFR vIII Mutant
Intervention(s):
Disease assessmentsTumor BiopsyBlood test

Connect. Empower. Inspire.